121 related articles for article (PubMed ID: 35082207)
21. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
Wu Y; Han Y; Li Q; Zhang P; Yuan P; Luo Y; Fan Y; Chen S; Cai R; Li Q; Xu H; Wang Y; Ma F; Wang J; Xu B
Breast Cancer Res Treat; 2022 Jun; 193(2):381-392. PubMed ID: 35297009
[TBL] [Abstract][Full Text] [Related]
22. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
23. A Four Country Study of Strangulation-related Alterations in Consciousness in Women who have Experienced Intimate Partner Violence: Co-occurrence with Traumatic Brain Injuries and Measures of Psychological Distress.
Adhikari SP; Daugherty JC; Quiroz Molinares N; Maldonado-Rodriguez N; Wallace C; Smirl J; Perez García M; De Los Reyes CJ; Hidalgo-Ruzzante N; van Donkelaar P; Valera E
J Neurotrauma; 2024 Apr; ():. PubMed ID: 38666734
[TBL] [Abstract][Full Text] [Related]
24. Community-Based Breast Cancer Screening Using Digital Breast Tomosynthesis Versus Digital Mammography: Comparison of Screening Performance and Tumor Characteristics.
Regen-Tuero HC; Ram S; Gass JS; Lourenco AP
AJR Am J Roentgenol; 2022 Feb; 218(2):249-257. PubMed ID: 34523954
[No Abstract] [Full Text] [Related]
25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
26. Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer.
Wei CT; Tsai IT; Wu CC; Hung WC; Hsuan CF; Yu TH; Hsu CC; Houng JY; Chung FM; Lee YJ; Lu YC
Int J Med Sci; 2021; 18(12):2689-2696. PubMed ID: 34104101
[No Abstract] [Full Text] [Related]
27. Utility of peripheral blood parameters in predicting breast cancer risk.
Okuturlar Y; Gunaldi M; Tiken EE; Oztosun B; Inan YO; Ercan T; Tuna S; Kaya AO; Harmankaya O; Kumbasar A
Asian Pac J Cancer Prev; 2015; 16(6):2409-12. PubMed ID: 25824773
[TBL] [Abstract][Full Text] [Related]
28. [Neutrophil/lymphocyte ratio in complete blood count as a mortality predictor in breast cancer].
Mimica X; Acevedo F; Oddo D; Ibáñez C; Medina L; Kalergis A; Camus M; Sánchez C
Rev Med Chil; 2016 Jun; 144(6):691-6. PubMed ID: 27598486
[TBL] [Abstract][Full Text] [Related]
29. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
[TBL] [Abstract][Full Text] [Related]
30. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Adrenal Venous Sampling in Patients with Bilateral Adrenal Masses and ACTH-Independent Cushing's Syndrome.
Acharya R; Dhir M; Bandi R; Yip L; Challinor S
World J Surg; 2019 Feb; 43(2):527-533. PubMed ID: 30232569
[TBL] [Abstract][Full Text] [Related]
32. An analysis of screen-detected invasive cancers by grade in the English breast cancer screening programme: are we failing to detect sufficient small grade 3 cancers?
Blanks RG; Wallis MG; Alison RJ; Given-Wilson RM
Eur Radiol; 2021 Apr; 31(4):2548-2558. PubMed ID: 32997179
[TBL] [Abstract][Full Text] [Related]
33. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
34. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis.
Duggan C; Trapani D; Ilbawi AM; Fidarova E; Laversanne M; Curigliano G; Bray F; Anderson BO
Lancet Oncol; 2021 Nov; 22(11):1632-1642. PubMed ID: 34653370
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test.
Iwamoto Y; Tatsumi F; Itoh T; Sasaki T; Mori S; Sugisaki T; Nakao E; Ohnishi M; Kusano T; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Kaku K; Mune T; Kaneto H
Sci Rep; 2022 Oct; 12(1):17680. PubMed ID: 36271288
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
Nakano K; Hosoda M; Yamamoto M; Yamashita H
Anticancer Res; 2014 Jul; 34(7):3819-24. PubMed ID: 24982408
[TBL] [Abstract][Full Text] [Related]
37. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
Sawada T; Akashi S; Nakamura S; Kuwayama T; Enokido K; Yoshida M; Hashimoto R; Ide T; Masuda H; Taruno K; Oyama H; Takamaru T; Kanada Y; Ikeda M; Kosugi N; Sato H; Nakayama S; Ata A; Tonouchi Y; Sakai H; Matsunaga Y; Matsutani A
Breast Cancer; 2017 Sep; 24(5):708-713. PubMed ID: 28238177
[TBL] [Abstract][Full Text] [Related]
38. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
40. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]